Drug Therapy

Consensus Recommendations From the American Acne & Rosacea Society on the Management of Rosacea, Part 5: A Guide on the Management of Rosacea

Author and Disclosure Information

The last article in this 5-part series provides a final overview of consensus recommendations from the American Acne & Rosacea Society (AARS) on the management of the common presentations of cutaneous rosacea. Optimal management of rosacea requires careful assessment of the patient’s clinical features with integration of therapies that adequately treat the presenting signs and symptoms. The treatment consensus recommendations from the AARS are based on 2 major common clinical presentations of rosacea: (1) centrofacial erythema with papulopustular lesions, and (2) centrofacial erythema without papulopustular lesions. The recommendations provided here serve to guide clinicians in their clinical practice.


 

Recommended Reading

Consensus Recommendations From the American Acne & Rosacea Society on the Management of Rosacea, Part 2: A Status Report on Topical Agents
MDedge Dermatology
Azelaic Acid Foam 15% in the Treatment of Papulopustular Rosacea: A Randomized, Double-blind, Vehicle-Controlled Study
MDedge Dermatology
Consensus Recommendations From the American Acne & Rosacea Society on the Management of Rosacea, Part 3: A Status Report on Systemic Therapies
MDedge Dermatology
Botulinum toxin tantalizes as a rosacea tamer
MDedge Dermatology
Consensus Recommendations From the American Acne & Rosacea Society on the Management of Rosacea, Part 4: A Status Report on Physical Modalities and Devices
MDedge Dermatology
Novel topical rosacea drug sails through phase III
MDedge Dermatology
Don’t overlook venerable benzoyl peroxide for acne
MDedge Dermatology
VIDEO: Tips for treating acne in breastfeeding women
MDedge Dermatology
VIDEO: A closer look at new pediatric acne guidelines
MDedge Dermatology
VIDEO: Practice pearls improve acne treatment
MDedge Dermatology

Related Articles